These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 9198818
41. Effects of nocloprost (9 beta-chloro-16,16-dimethyl PG E2) on absorption and disposition of antipyrine and sulfamethazine in healthy volunteers. Siegmund W, Zschiesche M, Franke G, Müller C, Amon I. Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):190-7. PubMed ID: 8500921 [Abstract] [Full Text] [Related]
46. Michaëlis--Menten kinetics of phenazone elimination in the perfused pig liver. Andreasen B, Tonnesen K, Rabol A, Keiding S. Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):1-13. PubMed ID: 576352 [Abstract] [Full Text] [Related]
47. Augmented antioxidant status in Tamoxifen treated postmenopausal women with breast cancer on co-administration with Coenzyme Q10, Niacin and Riboflavin. Yuvaraj S, Premkumar VG, Vijayasarathy K, Gangadaran SG, Sachdanandam P. Cancer Chemother Pharmacol; 2008 May; 61(6):933-41. PubMed ID: 17668211 [Abstract] [Full Text] [Related]
49. Concentration of histamine in serum and tissues of the primary ductal breast cancers in women. Sieja K, Stanosz S, von Mach-Szczypiński J, Olewniczak S, Stanosz M. Breast; 2005 Jun; 14(3):236-41. PubMed ID: 15927833 [Abstract] [Full Text] [Related]
51. Incidence of isoniazid acetylation phenotypes in North Indians. Gupta RC, Nair CR, Jindal SK, Malik SK. Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):259-64. PubMed ID: 6746149 [Abstract] [Full Text] [Related]
52. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients]. Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M. Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847 [Abstract] [Full Text] [Related]
53. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers. Augustynowicz-Kopeć E, Zwolska Z. Acta Pol Pharm; 2002 Oct; 59(6):452-7. PubMed ID: 12669770 [Abstract] [Full Text] [Related]
54. Association of serum adiponectin levels with breast cancer risk. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S. Clin Cancer Res; 2003 Nov 15; 9(15):5699-704. PubMed ID: 14654554 [Abstract] [Full Text] [Related]
57. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis. Singh SP, Pande JN, Khilnani GC, Kailash S. Indian J Chest Dis Allied Sci; 1996 Nov 15; 38(1):5-11. PubMed ID: 16892742 [Abstract] [Full Text] [Related]
58. Non-steroidal anti-inflammatory drug (NSAID) use and levels of a lipid oxidation marker in plasma and nipple aspirate fluids. Kato I, Chen G, Djuric Z. Breast Cancer Res Treat; 2006 May 15; 97(2):145-8. PubMed ID: 16322889 [Abstract] [Full Text] [Related]
59. The quality of life associated with prophylactic treatments for women with BRCA1/2 mutations. Grann VR, Jacobson JS, Sundararajan V, Albert SM, Troxel AB, Neugut AI. Cancer J Sci Am; 1999 May 15; 5(5):283-92. PubMed ID: 10526669 [Abstract] [Full Text] [Related]
60. C-reactive protein and risk of breast cancer. Zhang SM, Lin J, Cook NR, Lee IM, Manson JE, Buring JE, Ridker PM. J Natl Cancer Inst; 2007 Jun 06; 99(11):890-4. PubMed ID: 17551149 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]